Utilidad de las formulaciones Vimang® en pacientes con osteoartrosis de rodilla

Satisfactory analgesia was achieved in all patients from days 15-21 until 3 months. This effect was at least partly related to the decrease in synovial effusion observed in most affected joints and was independent of the reduction in synovial thickness observed on ultrasound. Both effects, the increase and decrease in synovial thickness, were independent of the analgesia. The inhibition of synovial membrane proliferation compared with initial values was significant only in group 2. Quality of life improved in all patients, due to pain relief and the increase in functional capacity as measured by the WOMAC index.